title: Ouabain-induced internalization and lysosomal degradation of the Na+/K+-ATPase.
abstract: Internalization of the Na(+)/K(+)-ATPase (the Na(+) pump) has been studied in the human lung carcinoma cell line H1299 that expresses YFP-tagged α1 from its normal genomic localization. Both real-time imaging and surface biotinylation have demonstrated internalization of α1 induced by ≥100 nm ouabain which occurs in a time scale of hours. Unlike previous studies in other systems, the ouabain-induced internalization was insensitive to Src or PI3K inhibitors. Accumulation of α1 in the cells could be augmented by inhibition of lysosomal degradation but not by proteosomal inhibitors. In agreement, the internalized α1 could be colocalized with the lysosomal marker LAMP1 but not with Golgi or nuclear markers. In principle, internalization could be triggered by a conformational change of the ouabain-bound Na(+)/K(+)-ATPase molecule or more generally by the disruption of cation homeostasis (Na(+), K(+), Ca(2+)) due to the partial inhibition of active Na(+) and K(+) transport. Overexpression of ouabain-insensitive rat α1 failed to inhibit internalization of human α1 expressed in the same cells. In addition, incubating cells in a K(+)-free medium did not induce internalization of the pump or affect the response to ouabain. Thus, internalization is not the result of changes in the cellular cation balance but is likely to be triggered by a conformational change of the protein itself. In physiological conditions, internalization may serve to eliminate pumps that have been blocked by endogenous ouabain or other cardiac glycosides. This mechanism may be required due to the very slow dissociation of the ouabain·Na(+)/K(+)-ATPase complex.
authors.affiliation: From the Department of Biological Chemistry, The Weizmann Institute of Science, Rehovot 76100, Israel.
authors.forename: Marina
authors.initials: M
authors.lastname: Cherniavsky-Lev
authors.forename: Ofra
authors.initials: O
authors.lastname: Golani
authors.forename: Steven J D
authors.initials: SJ
authors.lastname: Karlish
authors.forename: Haim
authors.initials: H
authors.lastname: Garty
mesh_terms: D000818:Animals; D001692:Biological Transport / Q000187:drug effects; D015153:Blotting, Western; D045744:Cell Line, Tumor; D003513:Cycloheximide / Q000494:pharmacology; D004705:Endocytosis / Q000187:drug effects*; D006801:Humans; D008164:Luminescent Proteins / Q000235:genetics / Q000378:metabolism; D052118:Lysosomal-Associated Membrane Protein 1 / Q000378:metabolism; D008247:Lysosomes / Q000378:metabolism*; D018613:Microscopy, Confocal; D010042:Ouabain / Q000494:pharmacology*; D011188:Potassium / Q000494:pharmacology; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D059748:Proteolysis / Q000187:drug effects; D011743:Pyrimidines / Q000494:pharmacology; D051381:Rats; D000254:Sodium-Potassium-Exchanging ATPase / Q000235:genetics / Q000378:metabolism*; D019061:src-Family Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism
chemical_list: C412373:AG 1879; D008164:Luminescent Proteins; D052118:Lysosomal-Associated Membrane Protein 1; D011500:Protein Synthesis Inhibitors; D011743:Pyrimidines; D010042:Ouabain; D003513:Cycloheximide; D019061:src-Family Kinases; C499076:ATP1A1 protein, human; C499075:Atp1a1 protein, rat; D000254:Sodium-Potassium-Exchanging ATPase; D011188:Potassium
keywords: Cardiac Glycosides; Endocytosis; Lysosomes; Na+/K+-ATPase; Ouabain; PI3-kinase (PI3K); Src